Cart
sales@molnova.com
Dabigatran ethyl ester
CAS No. 429658-95-7
Dabigatran ethyl ester( Dabigatran ethyl ester | BIBR-951CL | BIBR 951CL | BIBR951CL | UNII-KJ4EH9410G )
Catalog No. M14458 CAS No. 429658-95-7
A reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 47 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 158 | In Stock |
|
| 50MG | 270 | In Stock |
|
| 100MG | 424 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDabigatran ethyl ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionA reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.
-
DescriptionA reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM; an anticoagulant agent used to prevent stroke with atrial fibrillation.Thrombosis Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsDabigatran ethyl ester | BIBR-951CL | BIBR 951CL | BIBR951CL | UNII-KJ4EH9410G
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin
-
Research AreaCardiovascular Disease
-
IndicationThrombosis
Chemical Information
-
CAS Number429658-95-7
-
Formula Weight499.5643
-
Molecular FormulaC27H29N7O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OCC)CCN(C(C1=CC=C2C(N=C(CNC3=CC=C(C(N)=N)C=C3)N2C)=C1)=O)C4=NC=CC=C4
-
Chemical Nameβ-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wienen W, et al. Thromb Haemost. 2007 Jul;98(1):155-62.
2. Kansal AR, et al. Heart. 2012 Apr;98(7):573-8.
molnova catalog
related products
-
Enoxaparin sodium
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI).
-
Argatroban
Argatroban is a direct, selective thrombin inhibitor.
-
Imitrodast
Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
